Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: A double-blind, randomized, placebo-controlled clinical trial

Spinal Cord

Volumn 50, Issue 2, 2012, Pages 141-146

  Yang, M L ^a,b   Li, J J ^a,b   So, K F ^c,d   Chen, J Y H ^d   Cheng, W S ^d   Wu, J ^a,b   Wang, Z M ^a,b   Gao, F ^a,b   Young, W ^d,e  

^a CHINA REHABILITATION RESEARCH CENTER   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d China Spinal Cord Injury Network Ltd   (Hong Kong)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

chronic spinal cord injury; clinical trial; lithium; neural regeneration; neuropathic pain

Indexed keywords

LITHIUM CARBONATE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNCTIONAL INDEPENDENCE MEASURE; HUMAN; MALE; NAUSEA; NERVE REGENERATION; NEUROPATHIC PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD INJURY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; SPINAL CORD INJURIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856683661     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2011.126     Document Type: Article

References (43)

1. Yick LW, So KF, Cheung PT, Wu WT. Lithium chloride reinforces the regeneration-promoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury. J Neurotrauma 2004; 21: 932-943.
2. Wong YW, Tam S, So KF, Chen JY, Cheng WS, Luk KD et al. A three-month, open-label, single-arm trial evaluating the safety and pharmacokinetics of oral lithium in patients with chronic spinal cord injury. Spinal Cord 2011; 49: 94-98.
3. Zhao YD, Rahardja D, Qu Y. Sample size calculation for the Wilcoxon-Mann-Whitney test adjusting for ties. Stat Med 2008; 27: 462-468. (Pubitemid 351227880)
4. Wexler EM, Geschwind DH, Palmer TD. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry 2008; 13: 285-292. (Pubitemid 351272655)
5. Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM. Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 2003; 117: 55-61. (Pubitemid 36246503)
6. De Boer J, Wang HJ, Van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Ti s s u e E n g 2004; 10: 393-401. (Pubitemid 38580260)
7. De Boer J, Siddappa R, Gaspar C, van Apeldoorn A, Fodde R, van Blitterswijk C. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 2004; 34: 818-826. (Pubitemid 38581127)
8. Levitt LJ, Quesenberry PJ. The effect of lithium on murine hematopoiesis in a liquid culture system. N Engl J Med 1980; 302: 713-719. (Pubitemid 10132098)
9. Aglietta M, Leone A, Piacibello W. Effect of lithium on normal and chronic granulocytic leukemia colony forming cells (CFU-GM). Experientia 1981; 37: 1340-1341. (Pubitemid 12167377)
10. Gallicchio VS, Chen MG. Influence of lithium on proliferation of hematopoietic stem cells. Exp Hematol 1981; 9: 804-810. (Pubitemid 11051848)
11. Anton R, Kestler HA, Kuhl M. Beta-catenin signaling contributes to stemness and regulates early differentiation in murine embryonic stem cells. FEBS Lett 2007; 581: 5247-5254. (Pubitemid 350018750)
12. Schmidt MM, Guan K, Wobus AM. Lithium influences differentiation and tissue-specific gene expression of mouse embryonic stem (ES) cells in vitro. Int J Dev Biol 2001; 45: 421-429. (Pubitemid 32367539)
13. Ohteki T, Parsons M, Zakarian A, Jones RG, Nguyen LT, Woodgett JR et al. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J Exp Med 2000; 192: 99-104. (Pubitemid 30470810)
14. Willing AE, Zigova T, Milliken M, Poulos S, Saporta S, McGrogan M et al. Lithium exposure enhances survival of NT2N cells (hNT neurons) in the hemiparkinsonian rat. Eur J Neurosci 2002; 16: 2271-2278. (Pubitemid 36056951)
15. Vanelderen P, Rouwette T, Kozicz T, Roubos E, Van Zundert J, Heylen R et al. The role of brain-derived neurotrophic factor in different animal models of neuropathic pain. Eur J Pain 2010; 14: 473 e1-9.
16. Jing YY, Wang JY, Li XL, Wang ZH, Pei L, Pan MM et al. Nerve growth factor of red nucleus involvement in pain induced by spared nerve injury of the rat sciatic nerve. Neurochem Res 2009; 34: 1612-1618.
17. Shimizu T, Shibata M, Wakisaka S, Inoue T, Mashimo T, Yoshiya I. Intrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy. Pain 2000; 85: 59-64. (Pubitemid 30110744)
18. Jurgens TP, Schaefer C, May A. Treatment of cluster headache in pregnancy and lactation. Cephalalgia 2009; 29: 391-400.
19. Matharu M, Silver N. Cluster headache. Clin Evid (Online) 2008.
20. Leroux E, Ducros A. Cluster headache. Orphanet J Rare Dis 2008; 3: 20.
21. Loder E. Prophylaxis: headaches that never happen. Headache 2008; 48: 694-696. (Pubitemid 351678010)
22. Karakucuk EH, Yamanoglu T, Demirel O, Bora N, Zengil H. Temporal variation in drug interaction between lithium and morphine-induced analgesia. Chronobiol Int 2006; 23: 675-682. (Pubitemid 43879812)
23. Johnston IN, Westbrook RF. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors. Behav Brain Res 2004; 151: 151-158. (Pubitemid 38501437)
24. Zhang LJ, Han NL, Han JS. Regulation by lithium of the antagonistic effect of cholecystokinin octapeptide on ohmefentanyl-induced antinociception. Neuropharma-cology 1994; 33: 123-126. (Pubitemid 24086918)
25. Kim J, Kim JH, Kim Y, Cho HY, Hong SK, Yoon YW. Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats. Neurosci Lett 2009; 462: 303-307.
26. Maier SF, Wiertelak EP, Martin D, Watkins LR. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 1993; 623: 321-324. (Pubitemid 23275419)
27. Cirillo G, Cavaliere C, Bianco MR, De Simone A, Colangelo AM, Sellitti S et al. Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain. Cell Mol Neurobiol 2010; 30: 51-62.
28. Eaton MJ, Blits B, Ruitenberg MJ, Verhaagen J, Oudega M. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther 2002; 9: 1387-1395. (Pubitemid 35244164)
29. Tender GC, Kaye AD, Li YY, Cui JG. Neurotrophin-3 and Tyrosine-Kinase C Have Modulatory Effects on Neuropathic Pain in the Rat Dorsal Root Ganglia. Neurosurgery 2011; 68: 1048-1055.
30. Wilson-Gerwing TD, Stucky CL, McComb GW, Verge VM. Neurotrophin-3 significantly reduces sodium channel expression linked to neuropathic pain states. Exp Neurol 2008; 213: 303-314.
31. Chen Q, Smith GM, Shine HD. Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury. Exp Neurol 2008; 209: 497-509.
32. Ramer LM, McPhail LT, Borisoff JF, Soril LJ, Kaan TK, Lee JH et al. Endogenous TrkB ligands suppress functional mechanosensory plasticity in the deafferented spinal cord. J Neurosci 2007; 27: 5812-5822. (Pubitemid 350021075)
33. Young W. Review of lithium effects on brain and blood. Cell Transplant 2009; 18: 951-975.
34. Phiel CJ, Klein PS. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 2001; 41: 789-813. (Pubitemid 32385907)
35. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 2004; 22: 849-860. (Pubitemid 39166941)
36. Xie N, Li H, Wei D, LeSage G, Chen L, Wang S et al. Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis. Neuropharmacology 2010; 59: 444-451.
37. Wen YR, Tan PH, Cheng JK, Liu YC, Ji RR. Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc 2011; 110: 487-494.
38. Parkitna JR, Obara I, Wawrzczak-Bargiela A, Makuch W, Przewlocka B, Przewlocki R. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. J Pharmacol Exp Ther 2006; 319: 832-839.
39. Gault D, Morel-Fatio M, Albert T, Fattal C. Chronic neuropathic pain of spinal cord injury: what is the effectiveness of psychocomportemental management? Ann Phys Rehabil Med 2009; 52: 167-172.
40. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder. CNS Drugs 2009; 23: 225-240.
41. Fahy S, Lawlor BA. Lithium use in octogenarians. Int J Geriatr Psychiatry 2001; 16: 1000-1003. (Pubitemid 33039635)
42. Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. CNS Drugs 2009; 23: 331-349.
43. Yeung CK, Chan HH. Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol 2004; 5: 3-8. (Pubitemid 38316537)